Crossmark

Initial treatment of COPD with LABA-ICS or LABA-LAMA: real-world comparative effectiveness

Crossref DOI link: https://doi.org/10.1136/bmjresp-2025-003216

Published Online: 2025-12-18

Published Print: 2025-12

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Suissa, Samy https://orcid.org/0000-0002-1281-5296
Cherian, Mathew https://orcid.org/0000-0001-5843-3886
Dell’Aniello, Sophie https://orcid.org/0000-0002-4373-7876
Ernst, Pierre
Funding

Funding for this research was provided by:

Canadian Institutes of Health Research (MOP-49462)

Canada Foundation for Innovation (94480)
License Information

License valid from 2025-12-18